Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 17th Jun 2013 07:21

Antofagasta: UBS reduces target price from 1140p to 1050p, while upgrading from neutral to buy.ARM Holdings: Analysts at Numis have cut their view on the shares to reduce from hold. Associated British Foods: Nomura cuts target price from 1800p to 1650p downgrading to reduce.Atkins: Jefferies ups target price from 900p to 950p retaining a hold recommendation.Bovis Homes Group: UBS moves target price from 840p to 900p leaving its buy recommendation unchanged.BP: Jefferies ups target price from 450p to 500p and keeps a hold recommendation.British American Tabacco: Investec lowers target price from 3800p to 3750p, while its buy recommendation remains unchanged.Catlin: UBS starts with a target price of 475p and a neutral rating.Centrica: Goldman Sachs takes target price from 429p to 444p and maintains a neutral rating.Clean Air Power: Cantor Fitzgerald upgrades to buy with a target price of 175p..Drax Group: Goldman Sachs shifts target price from 681p to 684p and upgrades to neutral.First Group: UBS reduces target price from 122p to 100p reiterating a neutral rating.GlaxoSmithKline: UBS increases target price from 1450p to 1745p, while its neutral rating remains unaltered.Hikma Pharmaceuticals: Goldman Sachs initiates with a target price of 1170p and a buy recommendation.Immunodiagnostic Systems: Investec raises target price from 360p to 460p, but downgrades from buy to hold.Imperial Tabacco: Investec takes target price from 2370p to 2430p and reiterates a hold recommendation.Invensys: Canaccord Genuity starts with a target price of 420p and a hold recommendation.Majestic Wine: Investec moves target price from 480p to 495p and keeps a buy recommendation.National Grid: Goldman Sachs moves target price from 707p to 712p, while still recommending selling.Ophir Energy: UBS cuts target price from 550p to 500p, while keeping its buy recommendation.Pennon Group: Goldman Sachs shifts target price from 718p to 723p and retains a neutral rating.Resolution: JP Morgan increases target price from 273p to 302p maintaining a neutral rating.Shanks Group: Goldman Sachs ups target price from 107p to 112p and leaves its sell recommendation unchanged.SSE: Goldman Sachs raises target price from 1292p to 1335p, while staying with its sell recommendation.St James's Place: JP Morgan takes target price from 560p to 624p keeping an overweight rating.Tullow Oil: Jefferies reduces target price from 1800p to 1500p, while reiterating its buy recommendation.
More News
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.